17-OH Progesterone Test at Ayzal Lab

17-OH Progesterone at Ayzal Lab

The 17-Hydroxyprogesterone (17-OH Progesterone or 17-OHP) test is a highly specialized clinical laboratory investigation used to measure the concentration of a key steroid hormone precursor in the blood. This endocrine biomarker is synthesized primarily by the adrenal cortex as an intermediate step in the metabolic pathway that converts cholesterol into cortisol. In patients with specific enzymatic deficiencies, this pathway is disrupted, leading to an accumulation of 17-OHP. Measuring these levels is clinically vital for diagnosing congenital adrenal hyperplasia (CAH), monitoring therapeutic efficacy in affected patients, and evaluating cases of unexplained hyperandrogenism or hirsutism. Ayzal Lab, located in Lahore, Pakistan, utilizes advanced chemiluminescent immunoassay (CLIA) technology to deliver precise, reliable, and clinically validated hormone measurements to assist endocrinologists, pediatricians, and gynecologists in patient management.

Understanding the biochemical pathway of steroidogenesis is essential to appreciate the diagnostic value of this test. When the enzyme 21-hydroxylase is deficient or non-functional—which accounts for over 90% of congenital adrenal hyperplasia cases—the adrenal glands cannot efficiently produce cortisol or aldosterone. Consequently, the pituitary gland releases excess adrenocorticotropic hormone (ACTH) in an attempt to stimulate the adrenal cortex. This persistent stimulation causes hyperplasia of the adrenal glands and drives the overproduction of steroid precursors, specifically 17-OH progesterone. The excess 17-OHP is then shunted into the androgen synthesis pathway, resulting in elevated levels of testosterone and other potent androgens. By measuring the baseline or stimulated levels of 17-OHP, clinicians can accurately identify these enzymatic blocks, initiate life-saving steroid replacement therapies, and prevent severe adrenal crises in newborns.

Clinical Procedure: What to Expect

Patient Preparation

Appropriate patient preparation is essential to ensure the clinical validity of hormone testing, as steroid levels fluctuate based on diurnal rhythms, menstrual cycles, and pharmacological interventions. Patients undergoing the 17-OH Progesterone test at Ayzal Lab should adhere to the following preparation guidelines:

• Fasting Requirements: While a strict fast is not always mandatory, a fasting period of 8 to 12 hours is highly recommended to minimize dietary interference with lipid-based hormone precursors.
• Timing of Collection: For adult females, the blood sample should ideally be collected during the early morning (between 7:00 AM and 9:00 AM) when cortisol and related steroid precursors peak due to diurnal variation.
• Menstrual Cycle Phase: In menstruating women, the test should be scheduled during the early follicular phase (typically days 1 to 5 of the menstrual cycle) because 17-OHP levels naturally rise during the luteal phase.
• Medication Review: Patients must inform their physician and the laboratory staff of all current medications, particularly topical, oral, or inhaled corticosteroids (such as hydrocortisone, prednisone, or dexamethasone) and oral contraceptives, as these can suppress or alter endogenous steroid pathways.
• Stress Reduction: Physical and emotional stress can stimulate ACTH secretion and transiently elevate adrenal hormones. Patients are advised to rest quietly for 15 minutes prior to blood collection.

During the Procedure

The 17-OH Progesterone test is performed on a standard venous blood sample. Upon arrival at Ayzal Lab, the patient is seated comfortably in a blood collection chair. The phlebotomist verifies the patient’s identity and reviews the clinical indications and preparation compliance. A sterile tourniquet is applied to the upper arm to make the veins of the antecubital fossa more prominent. The selected venipuncture site is thoroughly cleansed with an antiseptic swab (70% isopropyl alcohol) and allowed to air dry. A sterile, single-use needle is inserted into the vein, and blood is drawn into a gold-top serum separator tube (SST) or a red-top clot activator tube. Once the collection is complete, the needle is gently withdrawn, and immediate pressure is applied to the site with a sterile cotton ball to prevent hematoma formation. A small adhesive bandage is applied, and the patient is advised to keep it in place for at least one hour. The entire venipuncture procedure takes less than five minutes and is associated with minimal discomfort, typically described as a mild, brief prick.

When is a 17-OH Progesterone Test Performed?

Congenital Adrenal Hyperplasia (CAH) Screening in Newborns

The primary clinical indication for measuring 17-OH progesterone is the screening and diagnosis of Congenital Adrenal Hyperplasia (CAH) in neonates. Infants born with the classic, salt-wasting form of 21-hydroxylase deficiency exhibit severe aldosterone and cortisol deficiencies within the first few weeks of life, leading to life-threatening hyponatremia, hyperkalemia, dehydration, and cardiovascular collapse. Pediatricians request this test immediately when a newborn presents with ambiguous genitalia, failure to thrive, unexplained vomiting, or profound dehydration. Rapid detection allows for immediate hormone replacement therapy, preventing critical adrenal crises and ensuring normal physiological development.

Evaluation of Female Hirsutism and Virilization

In adolescent and adult females, physicians order the 17-OH Progesterone test to investigate signs of virilization and androgen excess, such as severe hirsutism (excessive male-pattern hair growth on the face, chest, or back), treatment-resistant acne, male-pattern baldness (alopecia), and deepening of the voice. These symptoms often stem from late-onset or non-classic congenital adrenal hyperplasia (NCAH), a milder form of the enzyme deficiency that manifests during or after puberty. Differentiating NCAH from Polycystic Ovary Syndrome (PCOS) is critical, as the therapeutic management strategies for these endocrine disorders differ significantly.

Investigation of Menstrual Irregularities and Infertility

Reproductive endocrinologists frequently include 17-OH progesterone in the diagnostic workup for women presenting with primary amenorrhea, secondary amenorrhea, or oligomenorrhea associated with infertility. Chronic anovulation can be driven by mild adrenal enzyme defects that disrupt the hypothalamic-pituitary-ovarian axis. By measuring 17-OHP levels during the early follicular phase, clinicians can rule out adrenal steroidogenesis defects as the underlying cause of ovarian dysfunction, allowing for targeted ovulation induction or steroid suppression therapies to restore fertility.

Assessment of Ambiguous Genitalia in Infants

When an infant is born with atypical or ambiguous external genitalia—where the biological sex is not immediately apparent—a comprehensive endocrine and genetic evaluation is initiated. Excess adrenal androgens in female fetuses with 21-hydroxylase deficiency cause masculinization of the external genitalia in utero, while the internal reproductive organs (uterus and fallopian tubes) develop normally. A rapid 17-OH Progesterone test helps neonatologists and pediatric endocrinologists determine if adrenal hyperplasia is the underlying cause, guiding appropriate medical, surgical, and supportive care.

Monitoring Therapeutic Efficacy in CAH Patients

For patients diagnosed with classic or non-classic congenital adrenal hyperplasia, the 17-OH Progesterone test is performed periodically to monitor the effectiveness of glucocorticoid replacement therapy. The goal of treatment is to supply sufficient exogenous glucocorticoids to suppress excess ACTH secretion, thereby reducing the adrenal production of 17-OHP and subsequent androgens, while avoiding the complications of over-replacement (such as Cushingoid features and growth suppression). Regular monitoring of 17-OHP levels helps endocrinologists fine-tune medication dosages to maintain optimal metabolic balance.

What Does a 17-OH Progesterone Test Detect?

The 17-OH Progesterone test measures the concentration of 17-hydroxyprogesterone in the blood, providing critical insights into the functional capacity of the adrenal steroidogenic pathway. Specifically, this diagnostic test detects and evaluates:

• 21-Hydroxylase Deficiency: Marked elevations in 17-OHP levels indicate a deficiency in the 21-hydroxylase enzyme, the hallmark of classic and non-classic congenital adrenal hyperplasia.
• Classic Salt-Wasting CAH: Extremely high concentrations of 17-OHP in newborns point to the severe form of CAH, which requires urgent intervention to prevent adrenal crisis.
• Classic Simple Virilizing CAH: Elevated levels in infants presenting with ambiguous genitalia but without severe electrolyte imbalances indicate the simple virilizing form of the disease.
• Non-Classic Congenital Adrenal Hyperplasia (NCAH): Moderately elevated baseline levels, or significantly spiked levels following an ACTH stimulation test, detect late-onset adrenal hyperplasia in adolescents and adults.
• Adrenal Tumors: In rare cases, highly elevated levels of 17-OHP, along with other adrenal androgens, can indicate the presence of functional adrenal adenomas or carcinomas.
• Ovarian Source of Androgens: Normal or minimally elevated 17-OHP levels in the presence of high testosterone help rule out adrenal causes, pointing instead to ovarian conditions like Polycystic Ovary Syndrome (PCOS).
• Therapeutic Compliance and Control: Fluctuations in 17-OHP levels over time in treated CAH patients detect whether glucocorticoid therapy is adequate, inadequate, or excessive.

Turnaround Time and Report Access at Ayzal Lab

At Ayzal Lab, we understand that timely diagnostic results are crucial for clinical decision-making, particularly when managing newborn health or complex endocrine disorders. The 17-OH Progesterone test is processed in our specialized clinical chemistry and immunology department using state-of-the-art automated analyzers. The standard turnaround time for this hormone assay is typically within 24 to 48 hours from the time of sample collection. Once the clinical report is finalized and verified by our consultant pathologist, patients and referring physicians receive an automated SMS notification. Reports can be accessed securely online through the Ayzal Lab patient portal, downloaded as a PDF, or collected in person from our main diagnostic center in Lahore.

17-OH Progesterone Findings Overview

Structure / Parameter Evaluated	Normal Findings	Possible Abnormal Findings
Newborns (Preterm)	Higher baseline levels due to immature adrenal function (typically < 800 ng/dL)	Markedly elevated (> 2,000 ng/dL) suggesting Congenital Adrenal Hyperplasia (CAH)
Newborns (Term, < 3 days)	< 800 ng/dL (declining rapidly after birth)	Significantly elevated levels indicating classic 21-hydroxylase deficiency
Infants (> 3 days) and Children	< 100 ng/dL (low prepubertal levels)	Elevated levels indicating early-onset CAH or precocious puberty
Adult Males	< 220 ng/dL	Elevated levels in rare cases of adult-onset CAH or adrenal tumors
Adult Females (Follicular Phase)	< 80 ng/dL	Elevated levels (> 200 ng/dL) suggesting non-classic CAH or adrenal pathology
Adult Females (Luteal Phase)	< 290 ng/dL (naturally higher due to corpus luteum production)	Abnormally high levels requiring correlation with menstrual phase and clinical symptoms
ACTH Stimulation Test (Post-Stimulation)	< 1,000 ng/dL (normal response to synthetic ACTH)	> 1,500 ng/dL confirming non-classic congenital adrenal hyperplasia (NCAH)

Note: Diagnostic findings should always be interpreted by a qualified healthcare professional together with the patient’s symptoms, medical history, physical examination, laboratory investigations, previous imaging studies, and other relevant clinical information. Additional investigations or specialist consultation may be recommended depending on the findings.

Why Choose Ayzal Lab for 17-OH Progesterone?

• Experienced Healthcare Professionals: Our clinical laboratory is staffed by highly qualified pathologists, biochemists, and technologists specializing in endocrine assays.
• Patient-Focused Care: We prioritize patient comfort, safety, and confidentiality throughout the sample collection and reporting process.
• Quality Diagnostic Services: Ayzal Lab adheres to strict internal and external quality control protocols to ensure the highest accuracy in hormone testing.
• Professional Reporting: Our comprehensive reports include clear, age-specific, and gender-specific reference ranges to facilitate accurate clinical interpretation.
• Modern Diagnostic Approach: We utilize advanced automated chemiluminescent immunoassay (CLIA) platforms for precise molecular and hormone detection.
• Comfortable Environment: Our modern collection centers in Lahore are designed to provide a stress-free and hygienic experience for patients of all ages, including infants.
• Convenient Location: Easily accessible main facility and collection points across Lahore make diagnostic testing convenient for families.
• Commitment to Accurate Diagnosis: We are dedicated to providing reliable, timely, and evidence-based diagnostic insights to support patient care and clinical management.